Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Can f 1Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE10043.00020141030, Nilsson OB
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE3730.00020140127, Konradsen JR
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE2821.00020140127, Konradsen JR
1.5 - Atopic Dermatitis, Diagnosed2014Korea, Republic ofIgE254.00020140821, Choi JS
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14017.86020130111, Ott H
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7615.80020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE358.57020130605, Simon D
6.2 - General Population (Adults)2012SwedenIgE3712.43020120528, Patelis A
5.2.4 - Source Exposed, Adults (Symptoms, IgE)2012SwedenIgE10055.00020120420, Nilsson OB
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9921.21020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE9628.13020120528, Patelis A
10.1 - Normal Control2012BelgiumIgE273.70020110223, De Knop KJ
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164084.29020100301, Scala E
3.2.1 - Source Sensitized (IgE)2010SwedenIgE8967.00020100719, Madhurantakam C
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8617.44020101214, Gadisseur R
5.3.1 - Source Exposed (Symptoms, IgE)2010Spain / Sweden / USAIgE3748.65020100609, Mattsson L
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3724.32020090826, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009SwedenIgE3748.64020090109, Mattsson L
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2227.27020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2015.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2055.00020091005, Ott H
5.3.1 - Source Exposed (Symptoms, IgE)2007FinlandIgE3142.00020071207, Saarelainen S
3.2.1 - Source Sensitized (IgE)2006JapanIgE2040.00020061127, Kamata Y
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2004FinlandIgE2544.000
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2004FinlandIgE (IB)2552.000
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2004FinlandSPT2552.000
3.1.1 - Source Sensitized (SPT)1997NetherlandsIgE1978.900
Developed by
Panservice